about
Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicityComparative nephrotoxicity of SCH 21420 and amikacin in ratsSerial trough and peak amikacin levels in plasma as predictors of nephrotoxicityUnivariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosidesProspective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicinNephrotoxicity as a cause of acute kidney injury in children.Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways.Inhaled antibiotics for lower airway infections.Prospective comparative study of efficacy and toxicity of netilmicin and amikacinProspective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsProlonged endotoxemia enhances the renal injuries induced by gentamicin in rats.Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremiaImipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.Evaluation of aztreonam in the treatment of severe bacterial infections.Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infectionsIncrease of amikacin half-life during therapy in patients with renal insufficiency.Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.Infections in acute leukemia: a retrospective study of 148 patientsDrug-induced acute kidney injury in childrenComparative nephrotoxicity of gentamicin and tobramycin in ratsNetilmicin: clinical efficacy, tolerance, and toxicity.Netilmicin in gram-negative bacterial infections.Amikacin pharmacokinetics in pediatric patients with malignancyThe Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance.Aminoglycoside-induced hearing loss in humans.Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.Aminoglycosides: current role in antimicrobial therapy.Netilmicin: a review of toxicity in laboratory animals.Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of miceTherapeutic initiatives for the avoidance of aminoglycoside toxicity.Measurement of amikacin in serum by a latex agglutination inhibition test.
P2860
Q28327774-7A5C88A2-5581-47ED-B5D6-2643ADDE5311Q28328697-37674EDD-EC0B-4352-A6B3-43AFDC93EFC8Q28359459-5960BD6C-6F05-46BF-A098-23385145C66FQ28361967-01B60362-04ED-41C7-889F-1819A033BD11Q28366502-070EBBE2-8932-47C8-A6B6-26A464545717Q30319678-951FBDA6-3F64-44F6-8162-809C9A2B7E86Q30446543-F5FFB5B9-E007-4348-81D8-948743B6BE25Q30474223-4305B632-4A71-4ED9-A559-E1DA6369E91BQ33640488-25588F88-FA4E-4C28-855C-DFA36835E7ECQ33723887-6F9B0EE4-AE3A-41D8-8FB6-1FFCC6F8D0ACQ33727669-8E8F0008-7B89-46B6-99B8-9D5894AAD433Q33731809-F13BDB05-809E-4B9A-BAEE-CEA32B53EEDCQ35254820-14DB1BBC-9FA5-43B8-9D3D-9CDA56F366C6Q35298565-78F4669A-1279-41AF-BE00-44262A963EB1Q35571259-E30278A7-1F11-4DF1-9EEF-36B5AC9456F3Q35640457-DA6C9187-01E1-4A72-8539-6619B7C9F612Q35642347-C46157AC-DFDD-4089-B319-78477F1E5B1FQ35646167-FC449C42-5B3A-4E2B-A40D-A5539D01812DQ35668521-53E16DB1-EA5F-451B-9852-812C963F9859Q35669927-44205A95-E294-4950-A7F1-C69B5143CFBBQ35673926-2DE29087-97E7-4BD5-A5F1-5E70B195F41CQ35745123-F9BFFE43-D8D3-4F87-ADC8-1EA864AA633BQ35745224-213CC36D-5A00-473B-A563-94E751641743Q35806154-AD168013-0C72-4B09-881E-AA17FFA4E79EQ35954216-1984D41D-36B4-4A2E-9763-AD9CD63CFBC7Q36125552-B40763DD-D08F-4A85-831E-A2FFD0CF461BQ36465363-A4B0B1CC-0C6C-4792-AC3C-C173D9580EC7Q36466023-A75209D0-2C83-4C8D-92C8-784BBECC3219Q36477089-907F7721-8C21-4132-984E-F9E0D22F6DEBQ36486849-E58407A3-AC8F-43B1-83C7-EEE897151C9AQ37268122-08143AE5-AFA6-4C59-BA59-8B020F874AD9Q38070006-190DA884-C1BC-4A13-9A33-3C6A62394569Q38620778-09B2EBEA-5981-4BD2-B69F-F86DE0C052A6Q38676819-47350832-5D3F-42A7-84A3-AF88B19531ADQ38919674-C4C34A0D-931C-4548-8D9D-6687F44493D7Q39608639-35A4B5D6-3AF9-4ABF-99C0-03B125FFCCFCQ39771096-12483A30-F0BD-4FC7-8B7C-1001AA8E9059Q39817374-E24227FA-62D0-4ED8-B198-D1451E83F876Q39818301-6653607C-BD8C-4E8E-9DDF-EADF1BC0306DQ40204603-9BCEF04C-347C-4841-B2E1-9AE94FDC79DC
P2860
description
1977 nî lūn-bûn
@nan
1977 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Controlled comparison of amikacin and gentamicin
@ast
Controlled comparison of amikacin and gentamicin
@en
Controlled comparison of amikacin and gentamicin
@nl
type
label
Controlled comparison of amikacin and gentamicin
@ast
Controlled comparison of amikacin and gentamicin
@en
Controlled comparison of amikacin and gentamicin
@nl
prefLabel
Controlled comparison of amikacin and gentamicin
@ast
Controlled comparison of amikacin and gentamicin
@en
Controlled comparison of amikacin and gentamicin
@nl
P2093
P1476
Controlled comparison of amikacin and gentamicin
@en
P2093
C Q Edwards
J F Rogers
K L Baughman
P S Lietman
P304
P356
10.1056/NEJM197702172960701
P407
P577
1977-02-17T00:00:00Z